Chimera Investment downgraded to Sell from Hold at Wunderlich
Wunderlich believes that the severity of Chimera's loss on foreclosure of underlying loans has exceeded expectations, resulting in the company over-accreted discount and overpaid dividends. Price target is $2.50. :theflyonthewall.com
News For CIM From The Last 14 Days
Check below for free stories on CIM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
